FibroGen logo
FibroGen FGEN

Annual report 2025
added 03-16-2026

report update icon

FibroGen Long Term Debt Current 2011-2026 | FGEN

Annual Long Term Debt Current FibroGen

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 14.1 M 10.3 M 10.9 M 1.19 M 983 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
14.1 M 983 K 7.5 M

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.55 -0.42 % $ 1.06 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
AC Immune SA AC Immune SA
ACIU
1.03 M $ 3.25 3.83 % $ 229 M schweizSchweiz
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.79 0.03 % $ 4.31 M chinaChina
ADC Therapeutics SA ADC Therapeutics SA
ADCT
1.1 M $ 4.12 -1.9 % $ 105 M schweizSchweiz
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 6.55 -1.28 % $ 179 M israelIsrael
argenx SE argenx SE
ARGX
6.53 M $ 709.08 0.82 % $ 25 B niderlandNiderland
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.43 -4.99 % $ 8.25 B australiaAustralia
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 229.99 -0.45 % $ 5 B danmarkDanmark
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
843 K $ 6.09 0.58 % $ 496 M usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
BioCardia BioCardia
BCDA
333 K $ 1.29 1.24 % $ 27.3 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
1.6 M $ 14.55 1.32 % $ 213 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
11 K - - $ 521 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.62 -0.75 % $ 16.5 M usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.51 - $ 385 M britainBritain
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 94.12 3.95 % $ 27.2 B germanyGermany
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.5 -2.51 % $ 7.62 B israelIsrael